Journal of Clinical and Cellular Immunology
Open Access

HIV cure and latency: New targets and therapeutics

6^th International Conference and Expo on Immunology

October 24-26, 2016 Chicago, USA

Rachel Pasos

Triton College, USA

Posters & Accepted Abstracts: J Clin Cell Immunol

Abstract :

HIV has been a challenge to the scientific community in many areas such as HIV cure and Latency, HIV Immune enhancement and activation, concerning a vaccine, also adding to its complication, NeuroAIDS a disorder which has affected 50 percent of adults with AIDS according to NIH Aids.gov. There is also the challenge of HIV medication adverse effect and those who are on lifelong therapeutics, in which these challenges has been overcome by new targets and therapeutics that are sure to deliver. Presentation: HIV cell entry and NMDA receptors involvement, Germ line mutation, Endogenous Retrovirus. The identification of several HIV microorganisms. Immune Repertoire challenges.

Biography :

Email: r4ch3lp92@gmail.com